CastleArk Alternatives’s Zoetis ZTS Stock Holding History

CastleArk Alternatives’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-131,055	Closed	-$25.4M	–	307
2021 Q3	$25.4M	Buy	+131,055	New	+$26.4M	0.97%	25

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CastleArk Alternatives's ZTS Position: Q4 2021 in Review

CastleArk Alternatives sold out of Zoetis (ZTS) in Q4 2021, closing a stake of 131,055 shares — an estimated $25.4M sold.

CastleArk Alternatives first reported a position in ZTS in Q3 2021 and held it in 1 quarter. The position peaked at $25.4M in Q3 2021. 1,673 funds tracked by Wall St. Rank hold ZTS as of Q4 2021.

CastleArk Alternatives reported no remaining Zoetis position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 131,055 Zoetis shares in Q4 2021, an estimated $25.4M.
CastleArk Alternatives first reported a position in Zoetis in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's Zoetis position peaked at $25.4M in Q3 2021.
1,673 funds tracked by Wall St. Rank held Zoetis as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.